GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (ASX:TRI) » Definitions » 3-Year EBITDA Growth Rate

TrivarX (ASX:TRI) 3-Year EBITDA Growth Rate : 45.00% (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is TrivarX 3-Year EBITDA Growth Rate?

TrivarX's EBITDA per Share for the six months ended in Dec. 2023 was A$-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 45.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 58.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 31.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of TrivarX was 77.40% per year. The lowest was -75.00% per year. And the median was 24.90% per year.


Competitive Comparison of TrivarX's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, TrivarX's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TrivarX's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where TrivarX's 3-Year EBITDA Growth Rate falls into.



TrivarX 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


TrivarX  (ASX:TRI) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


TrivarX 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of TrivarX's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX (ASX:TRI) Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd Formerly Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development, and early-stage commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing monitoring, and management of depression and other mental health conditions. It serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets; Australia and the United States. The company has one operating segment, being the research, development, and commercialization of its Software as a Service product.